"TBSF" Human Immunoglobulin for Intravenous Use

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

normal immunoglobulin, Quantity: 60 g/L

Доступна с:

CSL Behring Australia Pty Ltd

ИНН (Международная Имя):

normal immunoglobulin

Фармацевтическая форма:

Injection, solution

состав:

Excipient Ingredients: maltose

Администрация маршрут:

Intravenous

Штук в упаковке:

50mL, 200mL

класс:

Medicine Listed (Export Only)

Тип рецепта:

(S1) This Schedule is intentionally blank

Терапевтические показания :

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Обзор продуктов:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизация:

Listed (Export Only)

Дата Авторизация:

2006-03-01